A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis. (Q37142451)
Jump to navigation
Jump to search
scientific article published on July 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis. |
scientific article published on July 2013 |
Statements
A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis (English)
W C Ports
S Khan
S Lan
M Lamba
C Bolduc
R Bissonnette
1 July 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference